ARTICLE | Clinical News
orBec beclomethasone dipropionate regulatory update
May 26, 2008 7:00 AM UTC
Dor BioPharma said it withdrew an MAA for orBec beclomethasone to treat gastrointestinal graft-versus-host disease (GvHD) after EMEA requested additional clinical trials to demonstrate efficacy of the...